table of content
1 Introduction to Research & Analysis Reports
1.1 Orphan Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Orphan Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Orphan Drugs Overall Market Size
2.1 Global Orphan Drugs Market Size: 2021 VS 2028
2.2 Global Orphan Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Orphan Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Orphan Drugs Players in Global Market
3.2 Top Global Orphan Drugs Companies Ranked by Revenue
3.3 Global Orphan Drugs Revenue by Companies
3.4 Global Orphan Drugs Sales by Companies
3.5 Global Orphan Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Orphan Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Orphan Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Orphan Drugs Players in Global Market
3.8.1 List of Global Tier 1 Orphan Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Orphan Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Orphan Drugs Market Size Markets, 2021 & 2028
4.1.2 Oncology
4.1.3 Gastrointestinal
4.1.4 Pulmonary
4.1.5 Neurology
4.1.6 Hematology
4.1.7 Cardio-vascular
4.1.8 Metabolic Disorders
4.1.9 Endocrinology
4.1.10 Infectious Diseases
4.1.11 Others
4.2 By Type - Global Orphan Drugs Revenue & Forecasts
4.2.1 By Type - Global Orphan Drugs Revenue, 2017-2022
4.2.2 By Type - Global Orphan Drugs Revenue, 2023-2028
4.2.3 By Type - Global Orphan Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Orphan Drugs Sales & Forecasts
4.3.1 By Type - Global Orphan Drugs Sales, 2017-2022
4.3.2 By Type - Global Orphan Drugs Sales, 2023-2028
4.3.3 By Type - Global Orphan Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Orphan Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Orphan Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail pharmacies
5.1.4 Others
5.2 By Application - Global Orphan Drugs Revenue & Forecasts
5.2.1 By Application - Global Orphan Drugs Revenue, 2017-2022
5.2.2 By Application - Global Orphan Drugs Revenue, 2023-2028
5.2.3 By Application - Global Orphan Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Orphan Drugs Sales & Forecasts
5.3.1 By Application - Global Orphan Drugs Sales, 2017-2022
5.3.2 By Application - Global Orphan Drugs Sales, 2023-2028
5.3.3 By Application - Global Orphan Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Orphan Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Orphan Drugs Market Size, 2021 & 2028
6.2 By Region - Global Orphan Drugs Revenue & Forecasts
6.2.1 By Region - Global Orphan Drugs Revenue, 2017-2022
6.2.2 By Region - Global Orphan Drugs Revenue, 2023-2028
6.2.3 By Region - Global Orphan Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Orphan Drugs Sales & Forecasts
6.3.1 By Region - Global Orphan Drugs Sales, 2017-2022
6.3.2 By Region - Global Orphan Drugs Sales, 2023-2028
6.3.3 By Region - Global Orphan Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Orphan Drugs Revenue, 2017-2028
6.4.2 By Country - North America Orphan Drugs Sales, 2017-2028
6.4.3 US Orphan Drugs Market Size, 2017-2028
6.4.4 Canada Orphan Drugs Market Size, 2017-2028
6.4.5 Mexico Orphan Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Orphan Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Orphan Drugs Sales, 2017-2028
6.5.3 Germany Orphan Drugs Market Size, 2017-2028
6.5.4 France Orphan Drugs Market Size, 2017-2028
6.5.5 U.K. Orphan Drugs Market Size, 2017-2028
6.5.6 Italy Orphan Drugs Market Size, 2017-2028
6.5.7 Russia Orphan Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Orphan Drugs Market Size, 2017-2028
6.5.9 Benelux Orphan Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Orphan Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Orphan Drugs Sales, 2017-2028
6.6.3 China Orphan Drugs Market Size, 2017-2028
6.6.4 Japan Orphan Drugs Market Size, 2017-2028
6.6.5 South Korea Orphan Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Orphan Drugs Market Size, 2017-2028
6.6.7 India Orphan Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Orphan Drugs Revenue, 2017-2028
6.7.2 By Country - South America Orphan Drugs Sales, 2017-2028
6.7.3 Brazil Orphan Drugs Market Size, 2017-2028
6.7.4 Argentina Orphan Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Orphan Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Orphan Drugs Sales, 2017-2028
6.8.3 Turkey Orphan Drugs Market Size, 2017-2028
6.8.4 Israel Orphan Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Orphan Drugs Market Size, 2017-2028
6.8.6 UAE Orphan Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Orphan Drugs Major Product Offerings
7.1.4 Novartis Orphan Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Novartis Key News
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Corporate Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company Orphan Drugs Major Product Offerings
7.2.4 Bristol-Myers Squibb Company Orphan Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Bristol-Myers Squibb Company Key News
7.3 Celgene
7.3.1 Celgene Corporate Summary
7.3.2 Celgene Business Overview
7.3.3 Celgene Orphan Drugs Major Product Offerings
7.3.4 Celgene Orphan Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Celgene Key News
7.4 F. Hoffmann-La Roche
7.4.1 F. Hoffmann-La Roche Corporate Summary
7.4.2 F. Hoffmann-La Roche Business Overview
7.4.3 F. Hoffmann-La Roche Orphan Drugs Major Product Offerings
7.4.4 F. Hoffmann-La Roche Orphan Drugs Sales and Revenue in Global (2017-2022)
7.4.5 F. Hoffmann-La Roche Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Orphan Drugs Major Product Offerings
7.5.4 Pfizer Orphan Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Pfizer Key News
7.6 Sanofi
7.6.1 Sanofi Corporate Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi Orphan Drugs Major Product Offerings
7.6.4 Sanofi Orphan Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Sanofi Key News
7.7 Alexion Pharmaceuticals
7.7.1 Alexion Pharmaceuticals Corporate Summary
7.7.2 Alexion Pharmaceuticals Business Overview
7.7.3 Alexion Pharmaceuticals Orphan Drugs Major Product Offerings
7.7.4 Alexion Pharmaceuticals Orphan Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Alexion Pharmaceuticals Key News
7.8 Eli Lilly and Company
7.8.1 Eli Lilly and Company Corporate Summary
7.8.2 Eli Lilly and Company Business Overview
7.8.3 Eli Lilly and Company Orphan Drugs Major Product Offerings
7.8.4 Eli Lilly and Company Orphan Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Eli Lilly and Company Key News
7.9 Novo Nordisk
7.9.1 Novo Nordisk Corporate Summary
7.9.2 Novo Nordisk Business Overview
7.9.3 Novo Nordisk Orphan Drugs Major Product Offerings
7.9.4 Novo Nordisk Orphan Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Novo Nordisk Key News
7.10 AstraZeneca
7.10.1 AstraZeneca Corporate Summary
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca Orphan Drugs Major Product Offerings
7.10.4 AstraZeneca Orphan Drugs Sales and Revenue in Global (2017-2022)
7.10.5 AstraZeneca Key News
7.11 Eisai
7.11.1 Eisai Corporate Summary
7.11.2 Eisai Orphan Drugs Business Overview
7.11.3 Eisai Orphan Drugs Major Product Offerings
7.11.4 Eisai Orphan Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Eisai Key News
7.12 Daiichi Sankyo Company
7.12.1 Daiichi Sankyo Company Corporate Summary
7.12.2 Daiichi Sankyo Company Orphan Drugs Business Overview
7.12.3 Daiichi Sankyo Company Orphan Drugs Major Product Offerings
7.12.4 Daiichi Sankyo Company Orphan Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Daiichi Sankyo Company Key News
7.13 Bayer
7.13.1 Bayer Corporate Summary
7.13.2 Bayer Orphan Drugs Business Overview
7.13.3 Bayer Orphan Drugs Major Product Offerings
7.13.4 Bayer Orphan Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Bayer Key News
7.14 GlaxoSmithKline
7.14.1 GlaxoSmithKline Corporate Summary
7.14.2 GlaxoSmithKline Business Overview
7.14.3 GlaxoSmithKline Orphan Drugs Major Product Offerings
7.14.4 GlaxoSmithKline Orphan Drugs Sales and Revenue in Global (2017-2022)
7.14.5 GlaxoSmithKline Key News
7.15 Merck & Co
7.15.1 Merck & Co Corporate Summary
7.15.2 Merck & Co Business Overview
7.15.3 Merck & Co Orphan Drugs Major Product Offerings
7.15.4 Merck & Co Orphan Drugs Sales and Revenue in Global (2017-2022)
7.15.5 Merck & Co Key News
7.16 Johnson & Johnson
7.16.1 Johnson & Johnson Corporate Summary
7.16.2 Johnson & Johnson Business Overview
7.16.3 Johnson & Johnson Orphan Drugs Major Product Offerings
7.16.4 Johnson & Johnson Orphan Drugs Sales and Revenue in Global (2017-2022)
7.16.5 Johnson & Johnson Key News
7.17 Biogen
7.17.1 Biogen Corporate Summary
7.17.2 Biogen Business Overview
7.17.3 Biogen Orphan Drugs Major Product Offerings
7.17.4 Biogen Orphan Drugs Sales and Revenue in Global (2017-2022)
7.17.5 Biogen Key News
7.18 Takeda
7.18.1 Takeda Corporate Summary
7.18.2 Takeda Business Overview
7.18.3 Takeda Orphan Drugs Major Product Offerings
7.18.4 Takeda Orphan Drugs Sales and Revenue in Global (2017-2022)
7.18.5 Takeda Key News
7.19 Amgen
7.19.1 Amgen Corporate Summary
7.19.2 Amgen Business Overview
7.19.3 Amgen Orphan Drugs Major Product Offerings
7.19.4 Amgen Orphan Drugs Sales and Revenue in Global (2017-2022)
7.19.5 Amgen Key News
8 Global Orphan Drugs Production Capacity, Analysis
8.1 Global Orphan Drugs Production Capacity, 2017-2028
8.2 Orphan Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Orphan Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Orphan Drugs Supply Chain Analysis
10.1 Orphan Drugs Industry Value Chain
10.2 Orphan Drugs Upstream Market
10.3 Orphan Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Orphan Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
